Adding PCSK9 drugs to cholesterol-lowering statins can slash bad cholesterol by as much as 81% in people with high cholesterol.
68
33
Evidence from Studies
Supporting (3)
68
Community contributions welcome
41
PCSK9 inhibitors safely and effectively lower LDL after heart transplantation: a systematic review and meta-analysis
Systematic Review With Meta-Analysis
Human
2023 Jan20
Ldl-cholesterol reduction with PCSK9 inhibitors: A meta-analysis of randomised controlled trials.
Systematic Review With Meta-Analysis
Human
Contradicting (2)
33
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.